Related Experiment Video
Updated: Jun 23, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m6A-YTHDF2-dependent manner
Mengting Ren1, Hanghai Pan1, Xinxin Zhou2
1Cancer Center, Department of Gastroenterology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
KIAA1429 promotes gastric cancer (GC) by destabilizing RASD1 mRNA, leading to increased tumor growth and metastasis. This finding establishes KIAA1429 as a potential prognostic biomarker and therapeutic target for GC patients.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- KIAA1429 is a key component of the m6A methyltransferase complex, linked to various cancer progressions.
- Its specific role and mechanisms in gastric cancer (GC) remain largely uncharacterized.
Purpose of the Study:
- To investigate the function of KIAA1429 in gastric cancer.
- To elucidate the molecular mechanisms underlying KIAA1429's role in GC progression.
Main Methods:
- Quantitative real-time PCR, Western blotting, and immunohistochemistry were used to assess KIAA1429 expression.
- In vitro and in vivo functional assays, alongside m6A-related techniques (MeRIP-seq, RIP, RNA pull-down), were employed to determine mechanisms.
Main Results:
- KIAA1429 expression is elevated in GC tissues and correlates with poor prognosis.
- KIAA1429 promotes GC cell proliferation, migration, invasion, and tumor growth/metastasis.
- KIAA1429 upregulates RASD1 by increasing m6A modification and enhancing mRNA stability in an m6A-YTHDF2-dependent manner.
Conclusions:
- KIAA1429 acts as an oncogene in GC by downregulating RASD1 via m6A-YTHDF2-mediated mRNA destabilization.
- KIAA1429 presents potential as a prognostic biomarker and therapeutic target for gastric cancer.
More Related Videos
Related Concept Videos
The Ras Gene
Ras is a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

